Treatment for Congenital Heart Disease

Phase-Based Progress Estimates
Boston Children's Hospital, Boston, MACongenital Heart Disease
24 - 35
All Sexes
What conditions do you have?

Study Summary

This trial will use MRI to study how d-TGA affects the brain, and how genes may play a role in modulating that effect.

Eligible Conditions
  • Congenital Heart Disease

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline

Delis-Kaplan Executive Function Scale (D-KEFS) composite score;

Trial Safety

Trial Design

0 Treatment Group

225 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
719 Previous Clinical Trials
5,324,255 Total Patients Enrolled

Eligibility Criteria

Age 24 - 35 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Who is eligible to partake in this research trial?

"This research study seeks 225 participants with congenital heart disease (CHD) aged between 24 to 35 years old. Most critically, applicants need to have taken part in the Boston Circulatory Arrest, pH and Hematocrit studies at Boston Childrens Hospital as children (n~300). Additionally, normally-developed age-matched adults able to give informed consent must also be included for MRI scans and limited IQ testing alongside more specialized neuropsychological tests which lack a normative reference." - Anonymous Online Contributor

Unverified Answer

How many participants are contributing to this trial's findings?

"Affirmative, according to records on the trial is still enrolling participants. This study was first advertised on July 1st 2022 and last updated 19th September of the same year. The aim is to recruit 225 patients from one medical centre." - Anonymous Online Contributor

Unverified Answer

Is the research team currently engaging new participants for this experiment?

"Affirmative. points out that the trial, which was launched on July 1st 2022 and recently revised on September 19th 2022, is actively recruiting 225 participants from a single medical site." - Anonymous Online Contributor

Unverified Answer

Is there an upper age limit for those eligible to participate in this trial?

"This research aims to include individuals between 24 and 35 years of age." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.